EpimAb Biotherapeutics and Almirall announced a license agreement on the development of bispecific antibodies for up to three undisclosed target pairs.
EpimAb Biotherapeutics and Almirall Announce Bispecific Antibody License Agreement Read More »
Immetas Therapeutics and GC Biopharma announced that they have entered into a research collaboration to discover and develop novel mRNA therapeutics for the treatment of a broad range of autoimmune diseases.
Scholar Rock Holding Corporation, a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, announced the pricing of an upsized underwritten public offering of 12,408,760 shares of its common stock at a public offering price of $6.85 per share.
The publication in ACS Catalysis , one of the world’s most influential scientific journals, compares the four best performing enzymes for PET degradation under industrial conditions and confirms the superior performance of Carbios’ enzyme Carbios proposes an international standardized method for enzyme comparison thereby confirming its position as the world leader of enzymatic PET depolymerization
POXEL SA, a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis and rare metabolic disorders, announced that it will participate at two upcoming investor conferences.
Poxel Announces its Participation at Upcoming October 2023 Investor Conferences Read More »
Kuros Biosciences, a leader in next-generation bone graft technologies, provides an update on its commercial activities for the first nine months of 2023 and announces changes and a transition in responsibilities within the Executive Management.
An increase in funding share and available lab space helps to keep the Bay State’s biotech and pharma sectors strong.
Massachusetts Biopharma Job Growth Surpasses that of Other States: Report Read More »
The MeiraGTx founder and CEO, now on her third career, didn’t take a typical path.
La neurogénesis adulta es la generación e integración de nuevas neuronas una vez el desarrollo embrionario del cerebro ha concluido. Este fenómeno está impulsado por la proliferación, supervivencia y diferenciación de una población de cé …
Un nuevo estudio revela cómo la dieta materna y el nacimiento prematuro pueden influir en la composición de la leche materna, concretamente en las citoquinas, importantes moléculas de comunicación celular. La investigación la ha realizado un equipo encabez …
Influencia de la dieta y del parto prematuro en la composición de la leche materna Read More »
